ASMR medallist warns of DIY genetics
11 June, 2004 by Susan WilliamsonAs the prospect of 'genetic passports' and DIY genetics tests grows more imminent, regulators need to get up to speed with scientific developments, this year's Australian Society for Medical Research medallist, Prof Mary Hendrix, has warned.
NHGRI confirms 'roo genome project support
10 June, 2004 by Melissa TrudingerThe NIH's National Human Genome Research Institute (NHGRI) has confirmed that it will provide funding to Australia's tammar wallaby sequencing project to allow at least 2X sequence coverage to be obtained.
News: Wallaby genome project to go ahead
02 June, 2004 by Melissa TrudingerThe wallaby genome project is poised to go ahead thanks to a last minute injection of $3 million into the project by the Victorian state government.
Paradigm shift in proteomics
01 June, 2004 by Graeme O'NeillProteomics, in which Australians are pioneers, can no longer be described as an emerging discipline, writes Graeme O'Neill.
Griffith team pinpoints genetic clue to migraine
26 May, 2004 by Graeme O'NeillResearchers at Griffith University's Genomics Research Centre have found an important clue to the cause of hormonally induced migraines, that may explain why women are three times more likely than men to suffer from migraine.
BioIT: EBI launches genome reviews database
17 May, 2004 by Kevin DaviesThe European Bioinformatics Institute (EBI) has launched Genome Reviews 1.0, a standardised resource for completely sequenced genomes, consisting of 256 chromosomes and plasmids, representing the complete genomes of 153 prokaryotic organisms.
Human Genetic Signatures acquires Danish technology
17 May, 2004 by Melissa TrudingerHuman Genetic Signatures has acquired the intellectual property and activities relating to intercalating nucleic acids (INAs) from Unest, a Danish company it helped to found.
RNA play: Benitec acquires US company Avocel
17 May, 2004 by Graeme O'NeillBrisbane RNA-interference (RNAi) technology specialist Benitec Ltd (ASX: BLT) has made a key strategic play in the US market by acquiring RNAi therapeutics pioneer Avocel Inc of Sunnivale, California.
Epilepsy susceptibility gene pinpointed
13 May, 2004 by Melissa TrudingerResearchers at the Women's and Children's Hospital (WCH) in Adelaide have identified variations in an ion channel gene that increases susceptibility to the most common form of epilepsy.
Singapore's Cygenics issues prospectus for $18 million ASX float
06 May, 2004 by Melissa TrudingerSingapore-based stem cell therapeutics company CyGenics has issued its prospectus for an AUD$18 million float on the ASX. With a pre-money valuation of $50 million, CyGenics will have a market capitalisation after the float of $68 million.
Wallaby genome project saved by Vic govt funds
05 April, 2004 by Melissa TrudingerThe wallaby genome project is poised to go ahead thanks to a last minute injection of $3 million into the project by the Victorian State Government.
New $10.5 million medical research building opens at St Vincents
02 April, 2004 by Melissa TrudingerMelbourne's St Vincent's Institute of Medical Research has opened its new AUD$10.5 million medical research building on the St Vincent's Hospital campus.
Growing replacement organs organically
31 March, 2004 by Graeme O'NeillAustralian scientists believe it may be possible to grow replacement organs organically, by providing organ-building stem cells with a 3-D template and leaving them to grow in situ, within the patient’s own body.
Bionomics files patent on angiogenesis gene trove
29 March, 2004 by Graeme O'NeillAdelaide-based meditech Bionomics LIMITED (ASX:BNO, US OTC:BMICY) has filed another international patent application on 496 potential gene targets for angiogenesis-inhibiting drugs.
Benitec defends patents
26 March, 2004 by Graeme O'NeillBrisbane-based biotech Benitec Limited (ASX: BLT) has fired the first shot in what may become a major international battle to determine ownership of key patents to RNA interference (RNAi), which has been described as the most powerful tool for gene technology since the invention of the polymerase chain reaction (PCR) two decades ago.
